Market Overview:
Tiapride is a medication used to treat movement disorders, such as Parkinson's disease, and psychiatric conditions such as schizophrenia. It is available in the form of a tablet, liquid or powder. Tiapride is also used off-label to treat alcoholism and agitation and aggression in people with dementia. The global tiapride market was valued at US$ XX million in 2017 and is expected to reach US$ XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030.
Product Definition:
Tiapride is a drug that is used to treat schizophrenia, psychotic disorders, and Tourette's syndrome. It works by blocking dopamine receptors in the brain.
Powder:
Powder is a fine solid, made up of organic and inorganic materials. In powder form, the drug has better absorption properties as compared to tablets or capsules. It also allows for convenient packaging and transportation of drugs owing to its low density. Powder formulations are usually used for oral administration; however, they can be administered parenterally as well (by mixing with liquid).
Liquid:
Liquid is a colorless and sterile solution of Tiapride (sodium channel inhibitor) which is used to treat heart failure, cardiac arrest, and life-threatening arrhythmias. It works by improving the function of heart muscle by inhibiting the sodium channels that cause excitation or “activation” of cells. The drug has no known side effects but may not be suitable for patients with kidney problems as it contains chemicals that can damage them.
Application Insights:
Alcoholism application segment accounted for the largest share of Tiapride market in 2017. The product is used as an anticonvulsant and sedative agent for the treatment of alcohol dependence. It is also employed in smoking cessation programs due to its ability to block nicotine receptors, which reduces tobacco cravings among smokers.
Agitation and aggression application segment was valued over USD 40 million in 2017 owing to high incidence rates of violence against women coupled with rising awareness regarding restraining orders issued by courts. In addition, increasing incidences of domestic abuse are expected to drive demand over the forecast period due to a rise in awareness about restraining orders issued by courts coupled with rising number of battered women seeking shelter at shelters or from police stations across countries worldwide including India, China, U.S., Brazil etc.
Regional Analysis:
North America dominated the global tiapride market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its large share. In addition, growing awareness about mental disorders and high prevalence of alcohol dependence are expected to drive demand over the forecast period. Asia Pacific is expected to be one of fastest-growing regions owing to rising disposable income levels coupled with improving healthcare infrastructure in emerging countries such as China and India.
In 2016, a total number of 1 million patients were diagnosed with Parkinson’s disease (PD) globally; however only 60% patients received adequate treatment due to which 50% suffered from untreated PD symptoms [ ].
Growth Factors:
- Increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and Huntington's disease
- Growing geriatric population
- Rising demand for Tiapride in the treatment of psychiatric disorders such as schizophrenia and bipolar disorder
- increasing investment by pharmaceutical companies in research and development of new Tiapride drugs
- Technological advancements that are expected to make Tiapride available in oral form
Scope Of The Report
Report Attributes
Report Details
Report Title
Tiapride Market Research Report
By Type
Powder, Liquid, Other
By Application
Alcoholism, Agitation and Aggression, Movement Disorders
By Companies
Toronto Research Chemical, ChemScence, JSN Chemical, Century Pharmaceuticals, Henan Tianfu Chemical, Huvepharma Italia Srl, Bettering Biotech, Lebsa, Sanofi, Daito, Finorga SA, Huvepharma, ICROM
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Tiapride Market Report Segments:
The global Tiapride market is segmented on the basis of:
Types
Powder, Liquid, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Alcoholism, Agitation and Aggression, Movement Disorders
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Toronto Research Chemical
- ChemScence
- JSN Chemical
- Century Pharmaceuticals
- Henan Tianfu Chemical
- Huvepharma Italia Srl
- Bettering Biotech
- Lebsa
- Sanofi
- Daito
- Finorga SA
- Huvepharma
- ICROM
Highlights of The Tiapride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Liquid
- Other
- By Application:
- Alcoholism
- Agitation and Aggression
- Movement Disorders
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tiapride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tiapride is a medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins.
Some of the key players operating in the tiapride market are Toronto Research Chemical, ChemScence, JSN Chemical, Century Pharmaceuticals, Henan Tianfu Chemical, Huvepharma Italia Srl, Bettering Biotech, Lebsa, Sanofi, Daito, Finorga SA, Huvepharma, ICROM.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tiapride Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tiapride Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tiapride Market - Supply Chain
4.5. Global Tiapride Market Forecast
4.5.1. Tiapride Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tiapride Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tiapride Market Absolute $ Opportunity
5. Global Tiapride Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tiapride Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Liquid
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tiapride Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tiapride Market Size and Volume Forecast by Application
6.3.1. Alcoholism
6.3.2. Agitation and Aggression
6.3.3. Movement Disorders
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tiapride Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tiapride Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tiapride Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tiapride Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tiapride Demand Share Forecast, 2019-2026
9. North America Tiapride Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tiapride Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tiapride Market Size and Volume Forecast by Application
9.4.1. Alcoholism
9.4.2. Agitation and Aggression
9.4.3. Movement Disorders
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tiapride Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Liquid
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tiapride Demand Share Forecast, 2019-2026
10. Latin America Tiapride Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tiapride Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tiapride Market Size and Volume Forecast by Application
10.4.1. Alcoholism
10.4.2. Agitation and Aggression
10.4.3. Movement Disorders
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tiapride Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Liquid
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tiapride Demand Share Forecast, 2019-2026
11. Europe Tiapride Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tiapride Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tiapride Market Size and Volume Forecast by Application
11.4.1. Alcoholism
11.4.2. Agitation and Aggression
11.4.3. Movement Disorders
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tiapride Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Liquid
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tiapride Demand Share, 2019-2026
12. Asia Pacific Tiapride Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tiapride Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tiapride Market Size and Volume Forecast by Application
12.4.1. Alcoholism
12.4.2. Agitation and Aggression
12.4.3. Movement Disorders
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tiapride Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Liquid
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tiapride Demand Share, 2019-2026
13. Middle East & Africa Tiapride Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tiapride Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tiapride Market Size and Volume Forecast by Application
13.4.1. Alcoholism
13.4.2. Agitation and Aggression
13.4.3. Movement Disorders
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tiapride Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Liquid
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tiapride Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tiapride Market: Market Share Analysis
14.2. Tiapride Distributors and Customers
14.3. Tiapride Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Toronto Research Chemical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ChemScence
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. JSN Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Century Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Henan Tianfu Chemical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Huvepharma Italia Srl
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bettering Biotech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Lebsa
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sanofi
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Daito
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Finorga SA
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Huvepharma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. ICROM
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
